Financhill
Back

Akari Therapeutics PLC Stock Predictions

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
27

AKTX
Akari Therapeutics PLC

Last Price:
2.27
Seasonality Move:
-8%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Akari Therapeutics PLC Stock Forecast

  • Is Akari Therapeutics PLC Stock Undervalued?
    The current Akari Therapeutics PLC [AKTX] share price is $2.30. The Score for AKTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Akari Therapeutics PLC Stock Go Up Next Year?

Data Unavailable

Akari Therapeutics PLC Stock Rating

Data Unavailable

Akari Therapeutics PLC Stock Price History

Is AKTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akaritx.com

52-Week Data

52-Week High:
4.40
52-Week Low:
1.08

Prediction Charts

Market Cap:
27.49M
Price in USD:
2.30
Volume:
11.74K
Beta:
-0.35

Technical Analysis

SMA50:
2.86
SMA100:
3.19
SMA200:
2.56
52-Wk Change:
-31.95%

Stock Predictions

  • Is Akari Therapeutics PLC stock public?
    Yes, Akari Therapeutics PLC is a publicly traded company.
  • What is the Akari Therapeutics PLC stock quote today?
    The Akari Therapeutics PLC stock price is 2.30 USD today.
  • How to buy Akari Therapeutics PLC stock online?
    You can buy Akari Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 2.13 2.21 2.21 2.13
Oct-24 2.25 2.27 2.44 2.21
Oct-25 2.26 2.36 2.50 2.25
Oct-28 2.30 2.40 2.49 2.30
Oct-29 2.47 2.50 2.50 2.36
Oct-30 2.58 2.41 2.58 2.32
Oct-31 2.44 2.40 2.57 2.40
Nov-1 2.54 2.78 3.15 2.43
Nov-4 2.91 2.43 2.91 2.20
Nov-5 2.39 2.43 2.50 2.22
Nov-6 2.43 2.32 2.43 2.21
Nov-7 2.28 2.43 2.43 2.28
Nov-8 2.52 2.45 2.56 2.28
Nov-11 2.32 2.30 2.38 2.21

Akari Therapeutics PLC Earnings

Data Unavailable

Akari Therapeutics PLC Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.